A carregar...
Real-life treatment of metastatic colorectal cancer with regorafenib: a single-centre review
BACKGROUND: Various tyrosine kinase signalling pathways affect the development and progression of colorectal cancer (crc). In clinical trials, regorafenib has been associated with a survival benefit in metastatic crc (mcrc). We assessed the safety and efficacy of regorafenib in real-world patients....
Na minha lista:
| Publicado no: | Curr Oncol |
|---|---|
| Main Authors: | , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Multimed Inc.
2017
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5576459/ https://ncbi.nlm.nih.gov/pubmed/28874891 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3747/co.24.3562 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|